Sara Knapke, MS, LGC

Loading...

Clinical Manager, Division of Human Genetics
Licensed Genetic Counselor, Division of Human Genetics

sara.knapke@cchmc.org

Burnet Campus

Make An Appointment

Existing PatientsMyChart Scheduling

AppointmentsCall Us to ScheduleAppointments1-513-636-3200

About

MS: Medical Genetics, University of Cincinnati Genetic Counseling Graduate Program, Cincinnati, OH 2004.

Certification: American Board of Genetic Counseling, 2005.

Licensure: Ohio, Kentucky, Tennessee.

Services and Specialties

Location

Burnet Campus

3333 Burnet Ave
Cincinnati, OH 45229

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Knapke, S; Nagarajan, R; Correll, J; Kent, D; Burns, K. Pediatric Blood and Cancer. 2012; 58(1):85-89.

Selected

Identification, management, and evaluation of children with cancer-predisposition syndromes. Knapke, S; Zelley, K; Nichols, KE; Kohlmann, W; Schiffman, JD. American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting. 2012; 576-584.

Cardiac genetic counseling services: Exploring downstream revenue in a pediatric medical center. Olson, M; Anderson, J; Knapke, S; Kushner, A; Martin, L; Statile, C; Shikany, A; Miller, EM. Journal of Genetic Counseling. 2025; 34(2):e1984.

A novel POT1-TPD presentation: A germline pathogenic POT1 variant discovered in a patient with newly diagnosed posterior fossa ependymoma. Gilene, S; Knapke, S; Leino, D; Roy, S; Raskin, S. Cancer Genetics. 2025; 292-293:38-43.

Current practice of cancer predisposition testing in pediatric patients with CNS tumors in the United States. Roy, B; Knapke, S; Pillay-Smiley, N; Zhang, X; Queen, K; Sisson, R. Pediatric Blood and Cancer. 2024; 71(1):e30725.

PATH-46. A NOVEL POT1-TPD PRESENTATION: A GERMLINE POT1 MUTATION DISCOVERED IN A PATIENT WITH NEWLY DIAGNOSED POSTERIOR FOSSA EPENDYMOMA. Gilene, S; Raskin, S; Roy, S; Knapke, S. Neuro-Oncology. 2023; 25(Supplement_5):v178-v178.

Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis. Theobald, KA; Susswein, LR; Marshall, ML; Roberts, ME; Mester, JL; Speyer, D; Williams, RNW; Knapke, SC; Solomon, SR; Murphy, PD; Klein, RT; Hruska, KS; Solomon, BD. Annals of Surgical Oncology. 2018; 25(12):3556-3562.

Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing. Chadwell, SE; He, H; Knapke, S; Lewis, J; Sisson, R; Hopper, J. Journal of Genetic Counseling. 2018; 27(5):1210-1219.

Gardner Fibroma: Clinical and Histopathologic Implications of Germline APC Mutation Association. Dahl, NA; Sheil, A; Knapke, S; Geller, JI. Journal of Pediatric Hematology/Oncology. 2016; 38(5):e154-e157.

The current state of cancer genetic counseling access and availability. Knapke, S; Haidle, JL; Nagy, R; Pirzadeh-Miller, S. Genetics in Medicine. 2016; 18(4):410-412.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

Loading ...